Nuveen’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-22,600
Closed -$6K – 3285
2022
Q1
$6K Buy
+22,600
New +$5.31M ﹤0.01% 3307
2021
Q2
– Sell
-25,800
Closed -$5K – 3396
2021
Q1
$5K Buy
+25,800
New +$5.08M ﹤0.01% 3325
2020
Q2
– Sell
-15,300
Closed -$3K – 3287
2020
Q1
$3K Buy
+15,300
New +$3.05M ﹤0.01% 3172

Other funds holding CME

Nuveen's CME Position: Q2 2026 in Review

Nuveen reduced its CME Group (CME) stake by 13% in Q2 2026, selling an estimated $37.5M and leaving 925,982 shares worth $204M. The position accounts for 0.05% of the portfolio, ranked #273.

Nuveen first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $663M in Q3 2019. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Nuveen held 925,982 shares of CME Group worth $204M as of Q2 2026.
  • Nuveen sold 135,575 CME Group shares in Q2 2026, an estimated $37.5M.
  • CME Group made up 0.05% of Nuveen's portfolio in Q2 2026, its #273 holding.
  • Nuveen first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's CME Group position peaked at $663M in Q3 2019.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.